FPAS
CORT icon

Focus Partners Advisor Solutions’s Corcept Therapeutics CORT Stock Holding History

Focus Partners Advisor Solutions’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Buy
+6,677
New +$403K ﹤0.01% 748
2025
Q4 		– Sell
-4,142
Closed -$324K – 1126
2025
Q3 		$324K Buy
+4,142
New +$300K ﹤0.01% 879
2025
Q2 		– Sell
-1,796
Closed -$204K – 1115
2025
Q1 		$204K Buy
+1,796
New +$109K ﹤0.01% 913

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Focus Partners Advisor Solutions's CORT Position: Q2 2026 in Review

Focus Partners Advisor Solutions opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 6,677 shares worth $581K. The stake represents ﹤0.01% of the portfolio and ranks #748 among its holdings. This is a return to the name: Focus Partners Advisor Solutions previously reported a position in CORT as recently as Q3 2025.

Focus Partners Advisor Solutions first reported a position in CORT in Q1 2025 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Focus Partners Advisor Solutions held 6,677 shares of Corcept Therapeutics worth $581K as of Q2 2026.
  • Corcept Therapeutics was a new Focus Partners Advisor Solutions position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #748 holding.
  • Focus Partners Advisor Solutions first reported a position in Corcept Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.